GOLETA, Calif.–(BUSINESS WIRE)–Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 17th Annual Morgan Stanley Global Healthcare Conference in New York.
Inogen’s President and CEO, Scott Wilkinson, and CFO, Alison Bauerlein, are scheduled to present on Wednesday, September 11, 2019 at 1:00 p.m. ET at the 17th Annual Morgan Stanley Global Healthcare Conference. Interested parties can access the live audio webcast from the Events section of the Investor Relations page on the Inogen website at www.inogen.com. A webcast replay will be available approximately one hour after the conclusion of the live presentation and will remain available for 90 days.
Inogen has used, and intends to continue to use, its Investor Relations website, http://investor.inogen.com/, as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. For more information, visit http://investor.inogen.com/.
About Inogen
Inogen is innovation in oxygen therapy. We are a medical technology company that develops, manufactures and markets innovative oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
For more information, please visit www.inogen.com.
Contacts
Investor Relations Contact:
Matt Bacso, CFA
mbacso@inogen.net
Media Contact:
Byron Myers
805-562-0503
Medidata Rave Companion, the industry’s first data entry companion, is recognized for improving the speed…
MOBILE, Ala.--(BUSINESS WIRE)--TruBridge, Inc. (NASDAQ: TBRG) (the “Company”), a healthcare solutions company, announced today that…
Leading technology-enabled solutions firm helps health care providers and payers improve quality and financial performance…
Connect Oregon streamlines Medicaid billing for community-based organizations (CBOs) using Unite Us Payments, increasing access…
Dr. Anthony P. Urbanek, D.D.S., M.S., M.D., one of the country's most highly regarded Oral…
BERLIN, GERMANY / ACCESSWIRE / March 26, 2024 / Diagnostic company SphingoTec announces a significant…